Skip to main content

and
  1. No Access

    Article

    The prevalence of mild cognitive impairment in breast cancer patients receiving chemotherapy according to the criteria of the National Institute on Aging-Alzheimer’s Association (NIA-AA)

    Breast cancer patients receiving chemotherapy can develop cognitive impairment. There is no gold standard for defining cognitive impairment. We applied the National Institute on Aging-Alzheimer’s Association (...

    E. A. C. Albers, J. M. Kieffer, S. B. Schagen in Journal of Cancer Survivorship (2024)